Pharmaceutical guidelines on the characteristics of prescription drug treatment for elderly people with heart-risk diseases

Not Applicable

• Conditions: Diabetes Mellitus; Systemic Arterial Hypertension; hyperlipidemia

• Registration Number: RBR-9dyq9jr
• Lead Sponsor: Fundação Universidade Federal de Sergipe

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-12-21
• Last Update Posted: 29 May 2023
• Study Completion: 2024-05-01

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Be 60 years of age or older; Carry out outpatient follow-up by outpatient physicians; Have at least one of the following diagnosed clinical conditions: systemic arterial hypertension, diabetes mellitus and dyslipidemia, according to the criteria recommended by the Brazilian guidelines for these clinical conditions; Present uncontrolled blood pressure and/or glycemic and/or lipid levels in accordance with established goals for the level of cardiovascular risk; Use medication for at least one of the chronic conditions mentioned above for more than six months

Exclusion Criteria

Diagnosis of resistant or secondary systemic arterial hypertension; Diabetes and/or secondary dyslipidemia; End stage of kidney disease; Liver disease; Cancer treatment; Acquired immunodeficiency syndrome or anticoagulation; Unstable psychiatric illness; Service provided by other pharmacists; Inability to attend scheduled appointments; Missing in more than two consecutive appointments; Withdrawal from participating in the study at any stage

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The Medication Regimen Complexity will be analyzed using the Medication Regimen Complexity Index instrument developed by George and collaborators in 2005, translated and validated to Brazilian Portuguese by Melchiors and collaborators in 2007. This instrument will only be applied to medications prescribed by the physician and/or prescribed by the pharmacist, evaluated based on information contained in the official monograph or medical prescription. This instrument includes 65 items divided into three sections in which the following factors will be evaluated, section A, dosage forms present in pharmacotherapy; section B, dose frequency for each drug in the pharmacotherapy; and section C, additional instructions, if present in the treatment. Each section will be evaluated individually, adding the result of the three sections to obtain the patient's individual Medication Regimen Complexity index. This assessment will be carried out in accordance with the recommendations contained in the instrument